Stabilization of bacteriophage during freeze drying

International Journal of Pharmaceutics

Volumn 389, Issue 1-2, 2010, Pages 168-175

  Puapermpoonsiri, U ^a   Ford, S J ^a   van der Walle, C F ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Bacteriophage; Lyophilization; Pseudomonas; Stabilizers; Staphylococcus

Indexed keywords

GELATIN; MACROGOL 6000; SUCROSE;

ARTICLE; BACTERIOLYSIS; BACTERIOPHAGE; BIOLOGICAL ACTIVITY; CULTURE MEDIUM; FREEZE DRYING; GELATINIZATION; MOISTURE; NONHUMAN; PRIORITY JOURNAL; SHELF LIFE; TEMPERATURE SENSITIVITY; THERMOSTABILITY;

BACTERIOPHAGES; CHEMISTRY, PHARMACEUTICAL; FREEZE DRYING; GELATIN; POLYETHYLENE GLYCOLS; SUCROSE; TIME FACTORS; TRANSITION TEMPERATURE;

EID: 77349086824     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.01.034     Document Type: Article

References (30)

1. Ackermann H.-W. Bacteriophage classification. In: Kutter E., and Sulakvelidze A. (Eds). Bacteriophages: Biology and Applications (2005), CRC Press, Boca Raton 67-89
2. Ackermann H.-W., Tremblay D., and Moineau S. Long-term bacteriophage preservation. World Fed. Cult. Collect. Newslett. 38 (2004) 35-40
3. Allison S.D., Chang B., Randolph T.W., and Carpenter J.F. Hydrogen bonding between sugar and protein is responsible for inhibition of dehydration-induced protein unfolding. Arch. Biochem. Biophys. 365 (1999) 289-298
4. Amin K., Dannenfelser R.M., Zielinski J., and Wang B. Lyophilization of polyethylene glycol mixtures. J. Pharm. Sci. 93 (2004) 2244-2249
5. Amorij J.P., Huckriede A., Wilschut J., Frijlink H.W., and Hinrichs W.L. Development of stable influenza vaccine powder formulations: challenges and possibilities. Pharm. Res. 25 (2008) 1256-1273
6. Bhat R., and Timasheff S.N. Steric exclusion is the principal source of the preferential hydration of proteins in the presence of polyethylene glycols. Protein Sci. 1 (1992) 1133-1143
7. Breen E.D., Curley J.G., Overcashier D.E., Hsu C.C., and Shire S.J. Effect of moisture on the stability of a lyophilized humanized monoclonal antibody formulation. Pharm. Res. 18 (2001) 1345-1353
8. Bruttin A., and Brussow H. Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy. Antimicrob. Agents Chemother. 49 (2005) 2874-2878
9. Carne H.R., and Greaves R.I. Preservation of corynebacteriophages by freeze-drying. J. Hyg. (Lond.) 72 (1974) 467-470
10. Carpenter J.F., Pikal M.J., Chang B.S., and Randolph T.W. Rational design of stable lyophilized protein formulations: some practical advice. Pharm. Res. 14 (1997) 969-975
11. Clark W.A., and Geary D. Proceedings: preservation of bacteriophages by freezing and freeze-drying. Cryobiology 10 (1973) 351-360
12. Croyle M.A., Cheng X., and Wilson J.M. Development of formulations that enhance physical stability of viral vectors for gene therapy. Gene Ther. 8 (2001) 1281-1290
13. Engel H.W., Smith L., and Berwald L.G. The preservation of mycobacteriophages by means of freeze drying. Am. Rev. Respir. Dis. 109 (1974) 561-566
14. Fortier L.-C., and Moineau S. Phage production and maintenance of stocks, including expected stock lifetimes. In: Clokie M.R.J., and Kropinski A.M. (Eds). Bacteriophages: Methods and Protocols, Vol. 1. Isolation, Characterization, and Interactions (2009), Humana Press, Totowa 203-219
15. Golshahi L., Seed K.D., Dennis J.J., and Finlay W.H. Toward modern inhalational bacteriophage therapy: nebulization of bacteriophages of Burkholderia cepacia complex. J. Aerosol Med. Pulm. Drug Deliv. 21 (2008) 351-360
16. Jepson C.D., and March J.B. Bacteriophage lambda is a highly stable DNA vaccine delivery vehicle. Vaccine 22 (2004) 2413-2419
17. Jiang S., and Nail S.L. Effect of process conditions on recovery of protein activity after freezing and freeze-drying. Eur. J. Pharm. Biopharm. 45 (1998) 249-257
18. Kendrick B.S., Chang B.S., Arakawa T., Peterson B., Randolph T.W., Manning M.C., and Carpenter J.F. Preferential exclusion of sucrose from recombinant interleukin-1 receptor antagonist: role in restricted conformational mobility and compaction of native state. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 11917-11922
19. Lee J.C., and Timasheff S.N. The stabilization of proteins by sucrose. J. Biol. Chem. 256 (1981) 7193-7201
20. Lee J.C., and Lee L.L. Preferential solvent interactions between proteins and polyethylene glycols. J. Biol. Chem. 256 (1981) 625-631
21. Pereira P., Kelly S.M., Cooper A., Mardon H.J., Gellert P.R., and van der Walle C.F. Solution formulation and lyophilisation of a recombinant fibronectin fragment. Eur. J. Pharm. Biopharm. 67 (2007) 309-319
22. Pikal M.J., Shah S., Roy M.L., and Putman R. The secondary drying stage of freeze-drying-drying kinetics as a function of temperature and chamber pressure. Int. J. Pharm. 60 (1990) 203-217
23. Puapermpoonsiri U., Spencer J., and van der Walle C.F. A freeze-dried formulation of bacteriophage encapsulated in biodegradable microspheres. Eur. J. Pharm. Biopharm. 72 (2009) 26-33
24. Rouse J.J., Mohamed F., and van der Walle C.F. Physical ageing and thermal analysis of PLGA microspheres encapsulating protein or DNA. Int. J. Pharm. 339 (2007) 112-120
25. Saleki-Gerhardt A., and Zografi G. Nonisothermal and isothermal crystallization of sucrose from the amorphous state. Pharm. Res. 11 (1994) 1166-1173
26. Schersch, K., Betz, O., Garidel, P., Muehlau, S., Bassarab, S., Winter, G., 2009. Systematic investigation of the effect of lyophilizate collapse on pharmaceutically relevant proteins. I. Stability after freeze-drying. J. Pharm. Sci., in press, doi:10.1002/jps.22000.
27. Searles J.A., Carpenter J.F., and Randolph T.W. The ice nucleation temperature determines the primary drying rate of lyophilization for samples frozen on a temperature-controlled shelf. J. Pharm. Sci. 90 (2001) 860-871
28. Wang W. Lyophilization and development of solid protein pharmaceuticals. Int. J. Pharm. 203 (2000) 1-60
29. Weber-Dabrowska B., Mulczyk M., and Gorski A. Bacteriophages as an efficient therapy for antibiotic-resistant septicemia in man. Transplant. Proc. 35 (2003) 1385-1386
30. Wright A., Hawkins C.H., Anggard E.E., and Harper D.R. A controlled clinical trial of a therapeutic bacteriophage perparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy. Clin. Otolaryngol. 34 (2009) 349-357